Yin, Y., Ye, Y., Su, L., Lin, R. (2026). Cadonilimab combined with FOLFIRINOX and bevacizumab as first-line treatment for microsatellite stable/proficient mismatch repair metastatic colorectal cancer: Updated survival analysis and safety outcomes from a multicenter, single-arm, phase 2 study (SYLT-026).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.121